Surgical Excision versus Antibiotic Treatment for Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Multicenter, Randomized, Controlled Trial
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The optimal treatment of nontuberculosis mycobacterial cervical lymphadenitis in children has not been established. Until recently, surgical excision was the standard treatment, but the number of reports of successful antibiotic treatment is increasing, which questions whether surgery is the preferred treatment. In this randomized, multicenter trial, we compared surgical excision with antibiotic treatment. METHODS: One hundred children with microbiologically proven nontuberculous mycobacterial cervicofacial lymphadenitis were randomly assigned to undergo surgical excision of the involved lymph nodes or to receive antibiotic therapy with clarithromycin and rifabutin for at least 12 weeks. The primary end point was cure, defined as regression of the lymph node enlargement by at least 75%, with cure of the fistula and total skin closure without local recurrence or de novo lesions after 6 months, as assessed by clinical and ultrasound evaluation. Secondary end points included complications of surgery and adverse effects of antibiotic therapy. RESULTS: Intention-to-treat analysis revealed that surgical excision was more effective than antibiotic therapy (cure rates, 96% and 66%, respectively; 95% confidence interval for the difference, 16%-44%). Treatment failures were explained neither by noncompliance nor by baseline or acquired in vitro resistance to clarithromycin or rifabutin. Surgical complications were seen in 14 (28%) of 50 patients; staphylococcal wound infection occurred in 6 patients, and a permanent grade 2 facial marginal branch dysfunction occurred in 1 patient. The vast majority of patients who were allocated to antibiotic therapy reported adverse effects (39 [78%] of 50 patients), including 4 patients who had to discontinue treatment. CONCLUSIONS: Surgical excision is more effective than antibiotic treatment for children with nontuberculous mycobacterial cervicofacial lymphadenitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Surgical excision is the recommended therapy for cervical lymphadenitis due to nontuberculous mycobacteria in children and has been associated with better outcomes than 3 months of 2-drug antibiotic therapy [62-64].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [62]
Citations
Cites
Wolinsky, E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.954 · Cited by 327 · cited 1×
“Nontuberculous mycobacteria (NTM) are a common cause of chronic cervicofacial lymphadenitis in children, especially those aged 1–5 years [1].”
BackgroundBergmans, A. M. C., Groothedde, J.-W., Schellekens, J. F. P., van Embden, J. D. A., Ossewaarde, J. M., & Schouls, A. L. M. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.916 · Cited by 193 · cited 1×
“and by PCR for Bartonella henselae [18].”
Management of atypical mycobacterial lymphadenitis in childhood: A review based on 380 cases
Schaad, U. B., Votteler, T. P., McCracken, G. H., & Nelson, J. D. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80506-5 · Cited by 176
Lymphadenitis Due to Nontuberculous Mycobacteria in Children: Presentation and Response to Therapy
Hazra, R., Robson, C. D., Perez‐Atayde, A. R., & Husson, R. N. (1999) · Clinical Infectious Diseases · doi:10.1086/515091 · Cited by 174 · cited 1×
“cofacial lymphadenitis in children [10–15].”
Bruijnesteijn van Coppenraet, E. S., Lindeboom, J. A., Prins, J. M., Peeters, M. F., Claas, E. C. J., & Kuijper, E. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2644-2650.2004 · Cited by 154 · cited 1×
“(InnoGenetics) [16, 17].”
Self-citationMOFENSON, L. M., Oleske, J. M., Serchuck, L. K., Dyke, R. V., & Wilfert, C. (2005) · Clinical Infectious Diseases · doi:10.1086/427295 · Cited by 151
Clarithromycin in the Treatment of Mycobacterium avium Lung Infections in Patients Without AIDS
Dautzenberg, B., Piperno, D., Diot, P., Truffot-Pernot, C., & Chauvin, J.-P. (1995) · CHEST Journal · doi:10.1378/chest.107.4.1035 · Cited by 147 · cited 1×
“promised patients [8, 9].”
Yen, T. L., Driscoll, C. L. W., & Lalwani, A. K. (2003) · Otology & Neurotology · doi:10.1097/00129492-200301000-00023 · Cited by 132 · cited 1×
“sified according to the House-Brackmann system [19, 20].”
Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown-Elliott, B. A., Shepherd, S., McLarty, J., Griffith, L., & Wallace, R. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-863oc · Cited by 125 · cited 1×
“complications [26, 27], which are hard to assess in young children.”
BackgroundMargileth, A. M. (1984) · American Journal of Diseases of Children · doi:10.1001/archpedi.1984.02140480019007 · Cited by 99 · cited 1×
“from 81% to 95% [2–7].”
Nontuberculous Mycobacterial Cervical Adenitis: A Ten‐Year Retrospective Review
Panesar, J., Higgins, K., Daya, H., Forte, V., & Allen, U. (2003) · The Laryngoscope · doi:10.1097/00005537-200301000-00028 · Cited by 90 · cited 1×
“Earlier retrospective studies have reported an incidence of nerve dysfunction varying from 0% to 9% [2, 5, 21–23].”
BackgroundTreatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin
Berger, C., Pfyffer, G. E., & Nadal, D. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70288-3 · Cited by 76 · cited 1×
“Successful use of the clarithromycin and rifabutin combination has been reported [12].”
BackgroundAntibiotic Therapy for Nontuberculous Mycobacterial Cervicofacial Lymphadenitis
Luong, A., McClay, J. E., Jafri, H. S., & Brown, O. (2005) · The Laryngoscope · doi:10.1097/01.mlg.0000168112.54252.92 · Cited by 74 · cited 1×
“cofacial lymphadenitis in children [10–15].”
Management of Nontuberculous Mycobacterial Cervical Lymphadenitis
Mandell, D. L., Wald, E. R., Michaels, M. G., & Dohar, J. E. (2003) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.129.3.341 · Cited by 69 · cited 1×
“Earlier retrospective studies have reported an incidence of nerve dysfunction varying from 0% to 9% [2, 5, 21–23].”
BackgroundRahal, A., Abela, A., Arcand, P., Quintal, M., LEBEL, M. H., & Tapiéro, B. (2001) · The Laryngoscope · doi:10.1097/00005537-200110000-00024 · Cited by 67 · cited 2×
“Earlier retrospective studies have reported an incidence of nerve dysfunction varying from 0% to 9% [2, 5, 21–23].”
BackgroundCervicofacial Lymphadenitis in Children Caused by Mycobacterium haemophilum
Lindeboom, J. A., Prins, J. M., Bruijnesteijn van Coppenraet, E. S., Lindeboom, R., & Kuijper, E. J. (2005) · Clinical Infectious Diseases · doi:10.1086/497834 · Cited by 65 · cited 1×
“by our study group [17, 25].”
Self-citationGreen, P. A., von Reyn, C. F., & Smith, R. P. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199307000-00015 · Cited by 59 · cited 1×
“cofacial lymphadenitis in children [10–15].”
Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children
Tessier, M. P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92920-3 · Cited by 57
Mycobacterium haemophilum and Lymphadenitis in Children
Bruijnesteijn van Coppenraet, L. E. S., Kuijper, E. J., Lindeboom, J. A., Prins, J. M., & Claas, E. C. J. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040589 · Cited by 57 · cited 2×
“by our study group [17, 25].”
Self-citationNontuberculous mycobacterial lymphadenitis in children
MALTEZOU, H. C., SPYRIDIS, P., & KAFETZIS, D. A. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199911000-00006 · Cited by 56
Zhang, X., Fei, Z., Chen, Y.-J., Fu, L.-A., Zhang, J., Liu, W., He, X., & Jiang, X. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.03.042 · Cited by 50 · cited 1×
“sified according to the House-Brackmann system [19, 20].”
Nontuberculous Mycobacterial Cervical Adenitis
Suskind, D. L., Handler, S. D., Tom, L. W. C., Potsic, W. P., & Wetmore, R. F. (1997) · Clinical Pediatrics · doi:10.1177/000992289703600705 · Cited by 48 · cited 1×
“from 81% to 95% [2–7].”
Tunkel, D. E. (1999) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.125.10.1109 · Cited by 43 · cited 1×
“Earlier retrospective studies have reported an incidence of nerve dysfunction varying from 0% to 9% [2, 5, 21–23].”
BackgroundAtypical tuberculosis in the pediatric patient: Implications for the pediatric surgeon
Sigalet, D. L., Lees, G., & Fanning, A. (1992) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(92)90181-6 · Cited by 38 · cited 1×
“from 81% to 95% [2–7].”
Danielides, V. G., Patrikakos, G., Moerman, M., Bonte, K., Dhooge, C., & Vermeersch, H. (2002) · ORL · doi:10.1159/000064138 · Cited by 32
Risk-Benefit Assessment of Therapies for Mycobacterium avium Complex Infections
Griffith, D. E. (1999) · Drug Safety · doi:10.2165/00002018-199921020-00006 · Cited by 30 · cited 1×
“complications [26, 27], which are hard to assess in young children.”
BackgroundShafran, S. D., Talbot, J., Chomyc, S., Davison, E., Singer, J., Phillips, P., Salit, I. E., Walmsley, S. L., Fong, I. W., Gill, M. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/515022 · Cited by 21 · cited 1×
“The correlation between treatment success and in vitro resistance to the antibiotics can be questioned in the case of NTM [28].”
BackgroundClarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections
Lindeboom, J. A. H., de Lange, J., & van den Akker, H. P. (1999) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/s1079-2104(99)70294-5 · Cited by 17
Self-citation
Research works printed but not linked: 1
- Benson, 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 53, 1
Cited by
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
To, K., Cao, R., Yegiazaryan, A., Owens, J., & Venketaraman, V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082541 · Cited by 264
“The increased risk of facial nerve damage can be a significant determining factor in whether to use antimicrobial therapy instead of surgical excision [84].”
BackgroundExtrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent Persons
Piersimoni, C., & Scarparo, C. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.070616 · Cited by 263
“In a recent well-designed trial including 100 children with culture- or PCR-confirmed diagnoses, surgery was more effective than chemotherapy; cure rates were 96% and 66%, respectively ( 11 ).”
BackgroundEpidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases
Sharma, S. K., & Upadhyay, V. (2020) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_902_20 · Cited by 255
Clinical manifestations of nontuberculous mycobacteria infections
Tortoli, E. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03014.x · Cited by 217
“almost always requires surgical excision of the lymph nodes involved [17].”
Background
Metadata
- Authors
- Lindeboom, J. A., Kuijper, E. J., Bruijnesteijn van Coppenraet, E. S., Lindeboom, R., & Prins, J. M.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Leiden University Medical Center (NL)
- Corresponding author
- Lindeboom, J. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 44
- Issue
- 8
- Pages
- 1057-1064
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2096318404
- Cited by
- 245
- References
- 28
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 6 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 20 · 2019: 12 · 2018: 15 · 2017: 14 · 2016: 14 · 2015: 17 · 2014: 13 · 2013: 8 · 2012: 14
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- UvA-DARE (University of Amsterdam) (publishedVersion)
- VU Research Portal (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Actinomycetales infections and treatment
- Keywords
- nontuberculous mycobacteria, cervicofacial lymphadenitis, surgical excision, antibiotic therapy, clarithromycin, rifabutin, children, treatment failure, adverse drug reactions, surgical complications, facial nerve dysfunction
- MeSH terms
- Adolescent, Anti-Bacterial Agents, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Lymph Node Excision, Tuberculosis, Lymph Node, Treatment Outcome, Clarithromycin, Rifabutin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.